Moderna
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.
MRNA Key Statistics
MRNA News
Moderna (NASDAQ:MRNA) stock has collapsed from its all-time high. However, the company is once again on the move — in a good way. The stock is up 68% over the p...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significa...
The European Patent Office has reportedly upheld the validity of Moderna’s (NASDAQ:MRNA) 949 patent for its COVID-19 vaccine in an ongoing dispute between the c...
Analyst ratings
46%
of 26 ratingsMore MRNA News
Novavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their shares soare...
Loading... Loading... On CNBC's “Mad Money Lightning Round,” Jim Cramer believes in Moderna, Inc. MRNA. On May 14, Evercore ISI Group analyst Cory Kasimov ini...
Moderna (MRNA) stock tumbled — and then rebounded — after the Food and Drug Administration delayed its RSV vaccine by roughly two weeks. X The news pushes bac...
Investors have put their hopes in Moderna's (NASDAQ: MRNA) next potential product, a respiratory syncytial virus (RSV) vaccine. That's because it represents a n...
Shares of Moderna, Inc. MRNA were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory s...
Novavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine. Moderna,...
Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the n...
